Mark A. Lovell

University of Kentucky, Lexington, KY 
Biochemistry, Analytical Chemistry
"Mark Lovell"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bradley-Whitman MA, Roberts KN, Abner EL, et al. (2017) A novel method for the rapid detection of post-translationally modified visinin-like protein 1 in rat models of brain injury. Brain Injury. 1-18
Lovell MA, Lynn BC, Fister S, et al. (2016) A Novel Small Molecule Modulator of Amyloid Pathology. Journal of Alzheimer's Disease : Jad
Bradley-Whitman MA, Abner E, Lynn BC, et al. (2015) A Novel Plasma Based Biomarker of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 47: 761-71
Lovell MA, Abner E, Kryscio R, et al. (2015) Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production. Oxidative Medicine and Cellular Longevity. 2015: 787805
Bradley-Whitman MA, Lovell MA. (2015) Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update. Archives of Toxicology. 89: 1035-44
Bradley-Whitman MA, Timmons MD, Beckett TL, et al. (2014) Nucleic acid oxidation: an early feature of Alzheimer's disease. Journal of Neurochemistry. 128: 294-304
Bradley-Whitman MA, Lovell MA. (2013) Epigenetic changes in the progression of Alzheimer's disease Mechanisms of Ageing and Development. 134: 486-495
Lovell MA, Bradley MA, Fister SX. (2012) 4-Hydroxyhexenal (HHE) impairs glutamate transport in astrocyte cultures. Journal of Alzheimer's Disease : Jad. 32: 139-46
Schmitt FA, Nelson PT, Abner E, et al. (2012) University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Current Alzheimer Research. 9: 724-33
Lyubartseva G, Lovell MA. (2012) A potential role for zinc alterations in the pathogenesis of Alzheimer's disease. Biofactors (Oxford, England). 38: 98-106
See more...